首页 | 本学科首页   官方微博 | 高级检索  
     

4种用药方案治疗2型糖尿病的成本-效果分析
引用本文:陈灵,张婉婷. 4种用药方案治疗2型糖尿病的成本-效果分析[J]. 中国药房, 2006, 17(10): 753-754
作者姓名:陈灵  张婉婷
作者单位:遵义医学院附属医院药剂科,遵义市,563003
摘    要:目的:评价4种用药方案治疗2型糖尿病的经济效果。方法:运用药物经济学原理对二甲双胍+格列吡嗪(A)、二甲双胍+吡格列酮(B)、二甲双胍+瑞格列奈(C)、二甲双胍+诺和灵30R(D)4种用药方案的成本-效果进行分析。结果:总有效率各组间无显著性差异,A、B、C、D组成本-效果比分别为2.21、3.21、2.63、6.54,B、C、D组相对于A组的增量成本-效果比分别为64.82、—6.41、51.25。结论:A方案为较佳选择。

关 键 词:2型糖尿病  降糖药  成本-效果分析
文章编号:1001-0408(2006)10-0753-02
收稿时间:2006-03-22
修稿时间:2006-04-16

Cost - Effectiveness Analysis of Therapeutic Schemes in the Treatment of Type Diabetes
CHEN Ling,ZHANG Wanting. Cost - Effectiveness Analysis of Therapeutic Schemes in the Treatment of Type Diabetes[J]. China Pharmacy, 2006, 17(10): 753-754
Authors:CHEN Ling  ZHANG Wanting
Affiliation:Dept. of Pharmacy, The Affiliated Hospital of Zunyi Medical College, Zunyi 563003, China
Abstract:OBJECTIVE:To discuss the cost-effectiveness of4therapeutic schemes in the treatment of Type2diabetes.METHODS:Cost-effectiveness analyses were made on4therapeutic schemes by using pharmacoeconomical principle,which were:metformin+clipizde(Scheme A),metformin+pioglitazone(Scheme B),metformin+repaglinide(Scheme C),and met-formin+novolin30R(Scheme D).RESULTS:There was no significant difference in the total effective rate among4schemes.The cost-effectiveness ratios in Scheme A,B,C and D were2.21,3.21,2.63,and6.54,respectively.The cost-effectiveness ratios increments in Scheme B,C,and D were64.82,—6.41,and51.25as against Scheme A.CONCLUSION:Among the4schemes,Scheme A is the preferable choice.
Keywords:Type2diabetes  Antidiabetic drugs  Cost-effectiveness analysis
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号